Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

Description

This non-blinded, non-randomized pre-post study will examine the impact of providing CGM sensors free of charge to adult patients of Fair Haven Community Health Care with poorly controlled type 2 diabetes on glycemic control and quality of life.

Conditions

Diabetes, Type 2 Diabetes, Type 2 Diabetes Mellitus - Poor Control

Talk to us

Study Overview

On this page

Study Details

Study overview

This non-blinded, non-randomized pre-post study will examine the impact of providing CGM sensors free of charge to adult patients of Fair Haven Community Health Care with poorly controlled type 2 diabetes on glycemic control and quality of life.

CGMs for All: Studying the Impact of Expanding CGM Access

Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

Condition
Diabetes
Intervention / Treatment

-

Contacts and Locations

New Haven

Fair Haven Community Health Care (FHCHC), New Haven, Connecticut, United States, 06520

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Provision of signed and dated informed consent form
  • * Stated willingness to comply with all study procedures and availability for the duration of the study
  • * Diagnosed with type 2 diabetes mellitus
  • * A1c greater than or equal to 8.0 within two weeks of the time of enrollment
  • * On insulin for at least one year +/- other antihyperglycemics
  • * Ability and willingness to wear CGM for 14-day periods throughout the trial period
  • * Ability and willingness to comply with provider-directed adjustments to medication regimen
  • * Inability to afford CGM sensors
  • * Insulin naïve
  • * Diabetic ketoacidosis (DKA) in previous 6 months
  • * End-Stage Renal Disease (ESRD)
  • * Contraindications to CGM use
  • * Active insurance plan that would provide enough of a subsidy for participant to feasibly purchase CGM sensors
  • * Pregnancy

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Yale University,

Kasia Lipska, MD MHS, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

2025-10